Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Deferred Taxes (2016 - 2025)

Altimmune (ALT) has disclosed Deferred Taxes for 8 consecutive years, with -$681000.0 as the latest value for Q1 2025.

  • Quarterly Deferred Taxes changed N/A to -$681000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$681000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$681000.0 for FY2025, N/A changed from the prior year.
  • Deferred Taxes for Q1 2025 was -$681000.0 at Altimmune, up from -$9.2 million in the prior quarter.
  • The five-year high for Deferred Taxes was -$681000.0 in Q1 2025, with the low at -$681000.0 in Q1 2025.